{
  "ticker": "VRTX",
  "year": 2026,
  "quarter": 1,
  "last_updated": "2026-02-27T08:51:19.568301",
  "count": 12,
  "transactions": [
    {
      "id": 1279,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2026-02-24",
      "transaction_shares": "546",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "7204"
    },
    {
      "id": 1280,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2026-02-24",
      "transaction_shares": "4981",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "138278"
    },
    {
      "id": 1281,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2026-02-24",
      "transaction_shares": "1518",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "57416"
    },
    {
      "id": 1282,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP, CO & FO",
      "transaction_date": "2026-02-24",
      "transaction_shares": "1744",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "47042"
    },
    {
      "id": 1283,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2026-02-24",
      "transaction_shares": "1453",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "40063"
    },
    {
      "id": 1284,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "McKechnie Duncan",
      "reporting_owner_cik": "0002062139",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2026-02-24",
      "transaction_shares": "873",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "22469"
    },
    {
      "id": 1285,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2026-02-24",
      "transaction_shares": "1627",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "47023"
    },
    {
      "id": 1287,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2026-02-24",
      "transaction_shares": "1144",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "14604"
    },
    {
      "id": 1288,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2026-02-24",
      "transaction_shares": "1627",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "19100"
    },
    {
      "id": 1289,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bunnage Mark E.",
      "reporting_owner_cik": "0002100735",
      "reporting_owner_position": "EVP, Chief Scientific Officer",
      "transaction_date": "2026-02-24",
      "transaction_shares": "582",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "7904"
    },
    {
      "id": 1290,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2026-02-24",
      "transaction_shares": "3547",
      "transaction_price": "485.11",
      "transaction_type": "F",
      "shares_after_transaction": "34797"
    },
    {
      "id": 1286,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2026-02-19",
      "transaction_shares": "23479",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "92521"
    }
  ]
}